Cargando…
Reduced Prepulse Inhibition as a Biomarker of Schizophrenia
The startle response is composed by a set of reflex behaviors intended to prepare the organism to face a potentially relevant stimulus. This response can be modulated by several factors as, for example, repeated presentations of the stimulus (startle habituation), or by previous presentation of a we...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067522/ https://www.ncbi.nlm.nih.gov/pubmed/27803654 http://dx.doi.org/10.3389/fnbeh.2016.00202 |
_version_ | 1782460656374513664 |
---|---|
author | Mena, Auxiliadora Ruiz-Salas, Juan C. Puentes, Andrea Dorado, Inmaculada Ruiz-Veguilla, Miguel De la Casa, Luis G. |
author_facet | Mena, Auxiliadora Ruiz-Salas, Juan C. Puentes, Andrea Dorado, Inmaculada Ruiz-Veguilla, Miguel De la Casa, Luis G. |
author_sort | Mena, Auxiliadora |
collection | PubMed |
description | The startle response is composed by a set of reflex behaviors intended to prepare the organism to face a potentially relevant stimulus. This response can be modulated by several factors as, for example, repeated presentations of the stimulus (startle habituation), or by previous presentation of a weak stimulus (Prepulse Inhibition [PPI]). Both phenomena appear disrupted in schizophrenia that is thought to reflect an alteration in dopaminergic and glutamatergic neurotransmission. In this paper we analyze whether the reported deficits are indicating a transient effect restricted to the acute phase of the disease, or if it reflects a more general biomarker or endophenotype of the disorder. To this end, we measured startle responses in the same set of thirteen schizophrenia patients with a cross-sectional design at two periods: 5 days after hospital admission and 3 months after discharge. The results showed that both startle habituation and PPI were impaired in the schizophrenia patients at the acute stage as compared to a control group composed by 13 healthy participants, and that PPI but not startle habituation remained disrupted when registered 3 months after the discharge. These data point to the consideration of PPI, but not startle habituation, as a schizophrenia biomarker. |
format | Online Article Text |
id | pubmed-5067522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-50675222016-11-01 Reduced Prepulse Inhibition as a Biomarker of Schizophrenia Mena, Auxiliadora Ruiz-Salas, Juan C. Puentes, Andrea Dorado, Inmaculada Ruiz-Veguilla, Miguel De la Casa, Luis G. Front Behav Neurosci Neuroscience The startle response is composed by a set of reflex behaviors intended to prepare the organism to face a potentially relevant stimulus. This response can be modulated by several factors as, for example, repeated presentations of the stimulus (startle habituation), or by previous presentation of a weak stimulus (Prepulse Inhibition [PPI]). Both phenomena appear disrupted in schizophrenia that is thought to reflect an alteration in dopaminergic and glutamatergic neurotransmission. In this paper we analyze whether the reported deficits are indicating a transient effect restricted to the acute phase of the disease, or if it reflects a more general biomarker or endophenotype of the disorder. To this end, we measured startle responses in the same set of thirteen schizophrenia patients with a cross-sectional design at two periods: 5 days after hospital admission and 3 months after discharge. The results showed that both startle habituation and PPI were impaired in the schizophrenia patients at the acute stage as compared to a control group composed by 13 healthy participants, and that PPI but not startle habituation remained disrupted when registered 3 months after the discharge. These data point to the consideration of PPI, but not startle habituation, as a schizophrenia biomarker. Frontiers Media S.A. 2016-10-18 /pmc/articles/PMC5067522/ /pubmed/27803654 http://dx.doi.org/10.3389/fnbeh.2016.00202 Text en Copyright © 2016 Mena, Ruiz-Salas, Puentes, Dorado, Ruiz-Veguilla and De la Casa. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Mena, Auxiliadora Ruiz-Salas, Juan C. Puentes, Andrea Dorado, Inmaculada Ruiz-Veguilla, Miguel De la Casa, Luis G. Reduced Prepulse Inhibition as a Biomarker of Schizophrenia |
title | Reduced Prepulse Inhibition as a Biomarker of Schizophrenia |
title_full | Reduced Prepulse Inhibition as a Biomarker of Schizophrenia |
title_fullStr | Reduced Prepulse Inhibition as a Biomarker of Schizophrenia |
title_full_unstemmed | Reduced Prepulse Inhibition as a Biomarker of Schizophrenia |
title_short | Reduced Prepulse Inhibition as a Biomarker of Schizophrenia |
title_sort | reduced prepulse inhibition as a biomarker of schizophrenia |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5067522/ https://www.ncbi.nlm.nih.gov/pubmed/27803654 http://dx.doi.org/10.3389/fnbeh.2016.00202 |
work_keys_str_mv | AT menaauxiliadora reducedprepulseinhibitionasabiomarkerofschizophrenia AT ruizsalasjuanc reducedprepulseinhibitionasabiomarkerofschizophrenia AT puentesandrea reducedprepulseinhibitionasabiomarkerofschizophrenia AT doradoinmaculada reducedprepulseinhibitionasabiomarkerofschizophrenia AT ruizveguillamiguel reducedprepulseinhibitionasabiomarkerofschizophrenia AT delacasaluisg reducedprepulseinhibitionasabiomarkerofschizophrenia |